These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 32681946)
1. Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling. Keum H; Kim TW; Kim Y; Seo C; Son Y; Kim J; Kim D; Jung W; Whang CH; Jon S J Control Release; 2020 Sep; 325():359-369. PubMed ID: 32681946 [TBL] [Abstract][Full Text] [Related]
2. Glutamine-Based Metabolism Normalization and Oxidative Stress Alleviation by Self-Assembled Bilirubin/V9302 Nanoparticles for Psoriasis Treatment. Jiang X; Huang S; Cai W; Wang P; Jiang Z; Wang M; Zhang L; Mao P; Chen L; Wang R; Sun T; Jiang Y; Yao Q; Chen R; Kou L Adv Healthc Mater; 2023 May; 12(13):e2203397. PubMed ID: 36690435 [TBL] [Abstract][Full Text] [Related]
3. Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells. Kim TW; Kim Y; Jung W; Kim DE; Keum H; Son Y; Jon S J Control Release; 2021 Mar; 331():74-84. PubMed ID: 33450316 [TBL] [Abstract][Full Text] [Related]
4. Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy. Lee Y; Kim H; Kang S; Lee J; Park J; Jon S Angew Chem Int Ed Engl; 2016 Jun; 55(26):7460-3. PubMed ID: 27144463 [TBL] [Abstract][Full Text] [Related]
5. Bilirubin nanoparticles ameliorate allergic lung inflammation in a mouse model of asthma. Kim DE; Lee Y; Kim M; Lee S; Jon S; Lee SH Biomaterials; 2017 Sep; 140():37-44. PubMed ID: 28624706 [TBL] [Abstract][Full Text] [Related]
6. Bilirubin Nanoparticles Protect Against Cardiac Ischemia/Reperfusion Injury in Mice. Ai W; Bae S; Ke Q; Su S; Li R; Chen Y; Yoo D; Lee E; Jon S; Kang PM J Am Heart Assoc; 2021 Oct; 10(20):e021212. PubMed ID: 34622671 [TBL] [Abstract][Full Text] [Related]
7. PEGylated bilirubin nanoparticle as an anti-oxidative and anti-inflammatory demulcent in pancreatic islet xenotransplantation. Kim MJ; Lee Y; Jon S; Lee DY Biomaterials; 2017 Jul; 133():242-252. PubMed ID: 28448818 [TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species-responsive supramolecular deucravacitinib self-assembly polymer micelles alleviate psoriatic skin inflammation by reducing mitochondrial oxidative stress. Yao L; Tian F; Meng Q; Guo L; Ma Z; Hu T; Liang Q; Li Z Front Immunol; 2024; 15():1407782. PubMed ID: 38799436 [TBL] [Abstract][Full Text] [Related]
9. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis. Lovato P; Norsgaard H; Tokura Y; Røpke MA J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805 [TBL] [Abstract][Full Text] [Related]
10. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Raychaudhuri SP; Jiang WY; Farber EM; Schall TJ; Ruff MR; Pert CB Acta Derm Venereol; 1999 Jan; 79(1):9-11. PubMed ID: 10086850 [TBL] [Abstract][Full Text] [Related]
13. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569 [TBL] [Abstract][Full Text] [Related]
14. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells. Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016 [TBL] [Abstract][Full Text] [Related]
15. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice. Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis. Furue K; Ulzii D; Tanaka Y; Ito T; Tsuji G; Kido-Nakahara M; Nakahara T; Furue M J Dermatol; 2020 Sep; 47(9):979-988. PubMed ID: 32677165 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy. Kim HR; Kim JC; Kang SY; Kim HO; Park CW; Chung BY Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921372 [TBL] [Abstract][Full Text] [Related]
18. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123 [TBL] [Abstract][Full Text] [Related]
19. Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions. de Boer OJ; van der Loos CM; Hamerlinck F; Bos JD; Das PK Arch Dermatol Res; 1994; 286(2):87-96. PubMed ID: 7512323 [TBL] [Abstract][Full Text] [Related]
20. BMP7 aberrantly induced in the psoriatic epidermis instructs inflammation-associated Langerhans cells. Borek I; Köffel R; Feichtinger J; Spies M; Glitzner-Zeis E; Hochgerner M; Sconocchia T; Krump C; Tam-Amersdorfer C; Passegger C; Benezeder T; Tittes J; Redl A; Painsi C; Thallinger GG; Wolf P; Stary G; Sibilia M; Strobl H J Allergy Clin Immunol; 2020 Apr; 145(4):1194-1207.e11. PubMed ID: 31870764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]